Tus Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 3.49%

Tus Pharmaceutical Group Co Ltd (000590) has an Asset Resilience Ratio of 3.49% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Tus Pharmaceutical Group Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥33.00 Million
≈ $4.83 Million USD Cash + Short-term Investments

Total Assets

CN¥945.59 Million
≈ $138.37 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2002–2022)

This chart shows how Tus Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. See Tus Pharmaceutical Group Co Ltd (000590) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Tus Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Tus Pharmaceutical Group Co Ltd worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥33.00 Million 3.49%
Total Liquid Assets CN¥33.00 Million 3.49%

Asset Resilience Insights

  • Limited Liquidity: Tus Pharmaceutical Group Co Ltd maintains only 3.49% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Tus Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Tus Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Tus Pharmaceutical Group Co Ltd (2002–2022)

The table below shows the annual Asset Resilience Ratio data for Tus Pharmaceutical Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 2.15% CN¥25.11 Million
≈ $3.67 Million
CN¥1.17 Billion
≈ $170.73 Million
-5.61pp
2021-12-31 7.76% CN¥75.15 Million
≈ $11.00 Million
CN¥967.83 Million
≈ $141.62 Million
-14.35pp
2017-12-31 22.12% CN¥193.23 Million
≈ $28.28 Million
CN¥873.74 Million
≈ $127.86 Million
+18.69pp
2014-12-31 3.42% CN¥20.09 Million
≈ $2.94 Million
CN¥586.82 Million
≈ $85.87 Million
+3.41pp
2006-12-31 0.02% CN¥85.15K
≈ $12.46K
CN¥545.36 Million
≈ $79.80 Million
+0.00pp
2005-12-31 0.01% CN¥93.07K
≈ $13.62K
CN¥664.58 Million
≈ $97.25 Million
0.00pp
2004-12-31 0.01% CN¥96.04K
≈ $14.05K
CN¥676.63 Million
≈ $99.01 Million
0.00pp
2003-12-31 0.02% CN¥130.61K
≈ $19.11K
CN¥685.16 Million
≈ $100.26 Million
-0.01pp
2002-12-31 0.02% CN¥180.63K
≈ $26.43K
CN¥724.86 Million
≈ $106.07 Million
--
pp = percentage points

About Tus Pharmaceutical Group Co Ltd

SHE:000590 China Drug Manufacturers - Specialty & Generic
Market Cap
$391.07 Million
CN¥2.67 Billion CNY
Market Cap Rank
#13789 Global
#4346 in China
Share Price
CN¥11.16
Change (1 day)
+0.54%
52-Week Range
CN¥8.99 - CN¥14.30
All Time High
CN¥26.17
About

Guhan Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells traditional Chinese medicines, chemical drugs, and health food in China. It operates through the Production and Sales of Traditional Chinese Medicine; Production and Sales of Western Medicine; and Other Operations segments. The company offers prescription and over-the-counter drugs, such as tonic and heal… Read more